Michiel J. van Esdonk

Author

Also Known As

M J van Esdonk, M van Esdonk, M. J. van Esdonk, M. van Esdonk, M.J. van Esdonk, Michiel J van Esdonk, Michiel J. Van Esdonk, Michiel J. van Esdonk, Michiel Joost van Esdonk, Michiel van Esdonk

Publications

592

Citations

H-Index

Concepts

All Affiliations

Centre for Human Drug Research Leiden University Medical Center Leiden University Haga Hospital Juliana Kinderziekenhuis

About

Michiel J. van Esdonk is an author at Centre for Human Drug Research specializing in pharmacodynamic modeling, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	104
2	Pharmacology	2	2	104
3	Health Sciences	1	1	14
4	Anesthesia	1	1	14
5	Drug Discovery	1	1	90

Michiel J. van Esdonk

Publications

442

Citations

H-Index

Page 1

	Year	Citations
First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma Kim S. de Valk, Marion M. Deken, Henricus J.M. Handgraaf, Clinical Cancer Research	2020	100
Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy Vasudev Kantae, Elke H. J. Krekels, Michiel J. van Esdonk, Metabolomics Translational MedicinePharmacokinetic ModelingPharmacodynamicsDrug PdPharmacometrics	2016	90
A zwitterionic near-infrared fluorophore for real-time ureter identification during laparoscopic abdominopelvic surgery Kim S. de Valk, Henricus J.M. Handgraaf, Marion M. Deken, Nature Communications	2019	69
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement Michelle Mellion, Lucienne Ronco, Cécile L. Berends, British Journal of Clinical Pharmacology	2021	37
Comprehensive evaluation of microneedle‐based intradermal adalimumab delivery <i>vs</i>. subcutaneous administration: results of a randomized controlled clinical trial Justin Jacobse, Wouter ten Voorde, Anushka Tandon, British Journal of Clinical Pharmacology	2021	26
Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for pharmacokinetic analysis Matthijs D. Kruizinga, Willem Birkhoff, Michiel J. van Esdonk, British Journal of Clinical Pharmacology	2019	20
Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062, a prodrug of galantamine C. J. G. Bakker, Jasper van der Aart, Ellen P. Hart, Alzheimer s & Dementia Translational Research & Clinical Interventions	2020	20
A Novel Somatostatin-Dopamine Chimera (BIM23B065) Reduced GH Secretion in a First-in-Human Clinical Trial Wadim M. I. de Boon, Michiel J. van Esdonk, Frederik E. Stuurman, The Journal of Clinical Endocrinology & Metabolism	2018	17
Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study Amadou Samb, Matthijs D. Kruizinga, Younes Tallahi, British Journal of Clinical Pharmacology	2021	16
Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy Subjects Michiel J. van Esdonk, Ian Lindeman, Pieter Okkerse, CPT Pharmacometrics & Systems Pharmacology Pain TherapyHealthy SubjectsAcute PainPressure PainPain Medicine	2018	14

Page 1